Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
about
FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.Multiscale Embedded Gene Co-expression Network Analysis.Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression.FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.EMT promoting transcription factors as prognostic markers in human breast cancer.FOXC1: an emerging marker and therapeutic target for cancer.Effects of targeted silencing of FOXC1 gene on proliferation and in vitro migration of human non-small-cell lung carcinoma cells.A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer.FOXC1, the new player in the cancer sandbox.MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.Research progress on the forkhead box C1.High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
P2860
Q33710341-64DEDBC9-182F-4625-8EE7-55ACEFB47F76Q34543873-AB5A53E0-2D6F-416B-8938-4749AB1CAE70Q35855670-2C313160-5988-43A9-9B58-AF434F57A654Q36009626-D7752EF1-1D60-47DD-AC6D-745CBADAEF33Q36098052-CDAFDF03-B75C-4169-A66A-8640C85C3FE4Q37689013-0B7092B8-D625-4C08-B636-71EADC2F5DEDQ38965324-2A02A1AB-9A04-4C2C-B09D-1FB8AF82D247Q39176111-73D00C14-A441-44C4-A6D9-A9C97B003187Q41003401-83F38FD8-941A-4992-BC56-4491588ECE5FQ42438922-272006B5-5AFC-4541-BA9B-85E7610B65B2Q44208783-09FC1A55-F7C7-4485-B8DD-16B21F81250AQ49624286-916EC477-E18A-482D-9760-5F169F63FC04Q50596382-420BDE0F-F7DE-4F6D-A221-CB5298984AFAQ51361643-5FF2E891-1856-41DF-8DAD-4A05C6CC6169Q52682253-BBD76492-BB55-4A22-889C-C03D6E7EC841Q53542144-FAED1F1E-626C-45FF-91DA-A82670B90576Q53701147-B6E82D2E-EA90-47CD-A552-B84B13A6D57FQ54279370-242EBF6A-8B1A-4FDF-A233-7B0DA6777AB2
P2860
Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Basal-like breast cancer defin ...... ive immunohistochemical study.
@en
type
label
Basal-like breast cancer defin ...... ive immunohistochemical study.
@en
prefLabel
Basal-like breast cancer defin ...... ive immunohistochemical study.
@en
P2093
P2860
P1476
Basal-like breast cancer defin ...... ive immunohistochemical study.
@en
P2093
Armando E Giuliano
Jaime M Shamonki
Jinhua Wang
Myung-Shin Sim
Partha S Ray
Sanjay P Bagaria
Shawn Steen
Xiaojiang Cui
P2860
P2888
P304
P356
10.1245/S10434-011-1657-8
P577
2011-03-18T00:00:00Z
P6179
1005758521